Search results for " healthcare"
Article
Finding Opportunities in Brazil
A McKinsey research report unveiled that, during early 2011, better healthcare and education were increasingly important to Brazil’s middle class. Sixty-three percent considered brand drugs relevant f…
Article
Early Communication with Regulators is Essential for SMEs
Approximately 10% of the program’s budget will be allocated to healthcare, demographic change, and well-being. A major objective is the elimination of fragmentation in the fields of scientific researc…
Article
Drugs, At What Cost?
In a new report, The Global Use of Medicines: Outlook through 2017, IMS Institute for Healthcare Informatics projects that in 2014 total global spending on medicines will, for the first time, exceed $…
Article
Introducing Supor Prime Filters: A Filtration Solution for High-Concentration Therapies
These drugs improve quality of life for our patients and reduce the burden on the healthcare system.
This trend towards higher concentration is a challenge for existing filters due to the higher p…
Article
Digitalization: The Route to Biopharma 4.0
Industry 4.0, also known as the Fourth Industrial Revolution (4IR), will result in the digital transformation of the manufacturing sector. It is propelled by transformative trends such as the prolif…
Article
The Smart Benefit of Digital Systems in Preclinical Studies
The advancement of smart drug development reaches far back in the drug development cycle, starting at the R&D phase and moving through the pipeline through to clinical studies. Data gathering…
Article
Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
In Asia-Pacific, single-use capacity will triple through a partnership with Wego, a large healthcare technology supplier in China that is already producing consumables for Cytiva in the region.
Cel…
Article
The Evolving Role of Starting Materials in Cell and Gene Therapy
The Evolving Role of Starting Materials in Cell and Gene Therapy
Accelerated approval pathways and growing demand for cell and gene therapies are putting pressure on providers of cellular starting m…
Article
Biosimilar Quality Requirements
…and interchangeable products, increasing access to life-saving medications, and potentially lowering healthcare costs through competition. Because of patient need, well-functioning biosimilar and int…
Article
The Good and Bad of Biosimilars
Biosimilars have been around for years, but the biopharma industry – as well as the healthcare community – has been slow to embrace them. Today, however, the competition is really beginning to heat …